IMMUNOPATHOGENESIS OF PSORIASIS: ANTIMICROBIAL PEPTIDES TAKE CENTRE STAGE

M. Gilliet

Abstract:Psoriasis is a chronic-relapsing inflammatory skin disease characterized by the aberrant activation of dendritic cells that stimulate pathogenic Th17 cells. Two main unsolved issues in the field are the nature of the initial trigger factor for the pathogenic Th17 cascade and the nature of the auto-antigen recognized by these Th17 cells. We found that plasmacytoid dendritic cells (PDC) and their activation to produce type I IFN are critical initial events that drive the development of Th17-mediated inflammation in psoriasis. Activation of PDC is driven by antimicrobial peptides such as LL37, hBD2, hBD3 and Lysozyme, which are overexpressed in psoriatic skin and which can trigger activation of TLR7 and TLR9 in PDC by forming complexes with self-nucleic acids released into the extracellular environment during cell turnover. In addition, we found that the anti-microbial peptide LL37 represents a direct auto-antigen recognized by pathogenic Th17 cells in psoriasis. Thus antimicrobial peptides are on one hand the innate trigger of dendritic cell activation, and, on the other hand, represent the antigenic stimulus and target for pathogenic Th17 cells in psoriasis.

Medicine,Biology